Related references
Note: Only part of the references are listed.Progress in drug delivery system for fibrosis therapy
Lei Xing et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities
Yankai Wen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Antigen- and Epitope-Delivering Nanoparticles Targeting Liver Induce Comparable Immunotolerance in Allergic Airway Disease and Anaphylaxis as Nanoparticle-Delivering Pharmaceuticals
Qi Liu et al.
ACS NANO (2021)
Myeloid-Cell-Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated Fibrosis
Xin Hou et al.
HEPATOLOGY (2021)
Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis
Mengying Hu et al.
NATURE NANOTECHNOLOGY (2021)
Role of liver sinusoidal endothelial cells in liver diseases
Jordi Gracia-Sancho et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia
Jordi Ribera et al.
ACS NANO (2021)
Lipid nanoparticle formulations for targeting leukocytes with therapeutic RNA in liver fibrosis
Matthias Bartneck
ADVANCED DRUG DELIVERY REVIEWS (2021)
Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis
Virender Kumar et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Asialoglycoprotein receptor targeted optical and magnetic resonance imaging and therapy of liver fibrosis using pullulan stabilized multi-functional iron oxide nanoprobe
Ariya Saraswathy et al.
SCIENTIFIC REPORTS (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Nanopharmaceutics: Part I-Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
Eliana B. Souto et al.
PHARMACEUTICS (2020)
Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities
Jinfang Zhang et al.
ACS NANO (2020)
Nanodrug with ROS and pH Dual-Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
Liteng Lin et al.
ADVANCED SCIENCE (2020)
Targeting of Hepatic Macrophages by Therapeutic Nanoparticles
Clara Colino et al.
FRONTIERS IN IMMUNOLOGY (2020)
Hyperbranched lipoid-based lipid nanoparticles for bidirectional regulation of collagen accumulation in liver fibrosis
Jian-Bin Qiao et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy
De Ji et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome
Lei Hou et al.
FRONTIERS IN IMMUNOLOGY (2020)
Light-triggered NO-releasing nanoparticles for treating mice with liver fibrosis
Hongxia Liang et al.
NANO RESEARCH (2020)
c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis
Jack Leslie et al.
NATURE METABOLISM (2020)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Golgi Apparatus-Targeted Chondroitin-Modified Nanomicelles Suppress Hepatic Stellate Cell Activation for the Management of Liver Fibrosis
Jingwen Luo et al.
ACS NANO (2019)
An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis
Yanping Li et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
Mengying Hu et al.
NATURE COMMUNICATIONS (2019)
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019
Bedair Dewidar et al.
CELLS (2019)
Titanium Dioxide Nanoparticles Enhance Leakiness and Drug Permeability in Primary Human Hepatic Sinusoidal Endothelial Cells
Jie Kai Tee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Engineered Relaxin as theranostic nanomedicine to diagnose and ameliorate liver cirrhosis
Beata Nagorniewicz et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Combatting Fibrosis: Exosome-Based Therapies in the Regression of Liver Fibrosis
Li Chen et al.
HEPATOLOGY COMMUNICATIONS (2019)
Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
Devaraj Ezhilarasan et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)
Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis
Jian-Bin Qiao et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Clinical phase 1b study results for safety, pharmacokinetics and efficacy of ND-L02-s0201, a novel targeted lipid nanoparticle delivering HSP47 SIRNA for the treatment of Japanese patients with advanced liver fibrosis
N. Sakamoto et al.
JOURNAL OF HEPATOLOGY (2018)
Risk assessment of silica nanoparticles on liver injury in metabolic syndrome mice induced by fructose
Jianmei Li et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2018)
Inorganic Nanomaterials as Highly Efficient Inhibitors of Cellular Hepatic Fibrosis
Fei Peng et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Changyu Zhu et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Type 3 cytokines IL-17A and IL-22 drive TGF-β-dependent liver fibrosis
Thomas Fabre et al.
SCIENCE IMMUNOLOGY (2018)
Role of miR-223 in the pathophysiology of liver diseases
Dan Ye et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis
Ji Wang et al.
DRUG DELIVERY (2018)
Oral Exposure to Silver Nanoparticles or Silver Ions May Aggravate Fatty Liver Disease in Overweight Mice
Jianbo Jia et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2017)
The Origin of Fibrogenic Myofibroblasts in Fibrotic Liver
Tatiana Kisseleva
HEPATOLOGY (2017)
Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
CD44 is a key player in non-alcoholic steatohepatitis
Stephanie Patouraux et al.
JOURNAL OF HEPATOLOGY (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Liver Sinusoidal Endothelial Cell: An Update
Laurie D. DeLeve et al.
SEMINARS IN LIVER DISEASE (2017)
Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells
Young-Sun Lee et al.
SCIENTIFIC REPORTS (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
The stellate cell system (vitamin A-storing cell system)
Haruki Senoo et al.
ANATOMICAL SCIENCE INTERNATIONAL (2017)
Bolstering cholesteryl ester hydrolysis in liver: A hepatocyte-targeting gene delivery strategy for potential alleviation of atherosclerosis
Hongliang He et al.
BIOMATERIALS (2017)
Liver macrophages in tissue homeostasis and disease
Oliver Krenkel et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrin αvβ3 expression with an MRI modality in mice
Feng Li et al.
BIOMATERIALS (2016)
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2016)
Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model
Sook In Chung et al.
JOURNAL OF HEPATOLOGY (2016)
Clinical Advancements in the Targeted Therapies against Liver Fibrosis
Ruchi Bansal et al.
MEDIATORS OF INFLAMMATION (2016)
Simplified quantification method for in vivo SPECT/CT imaging of asialoglycoprotein receptor with 99mTc-p(VLA-co-VNI) to assess and stage hepatic fibrosis in mice
Deliang Zhang et al.
SCIENTIFIC REPORTS (2016)
Pathobiology of liver fibrosis: a translational success story
Youngmin A. Lee et al.
GUT (2015)
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
Tian Lan et al.
PLOS ONE (2015)
The global burden of liver disease: a challenge for methods and for public health
Peter Byass
BMC MEDICINE (2014)
Angiotensin-II Type 1 Receptor-Mediated Janus Kinase 2 Activation Induces Liver Fibrosis
Michaela Granzow et al.
HEPATOLOGY (2014)
Relaxin Modulates Human and Rat Hepatic Myofibroblast Function and Ameliorates Portal Hypertension In Vivo
Jonathan A. Fallowfield et al.
HEPATOLOGY (2014)
NLRP3 Inflammasome Activation Results in Hepatocyte Pyroptosis, Liver Inflammation, and Fibrosis in Mice
Alexander Wree et al.
HEPATOLOGY (2014)
Macrophage heterogeneity in liver injury and fibrosis
Frank Tacke et al.
JOURNAL OF HEPATOLOGY (2014)
Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
Bi-Sen Ding et al.
NATURE (2014)
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
Yizhou Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Origin of myofibroblasts in the fibrotic liver in mice
Keiko Iwaisako et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages
Chunbai He et al.
BIOMATERIALS (2013)
Macrophage microvesicles induce macrophage differentiation and miR-223 transfer
Noura Ismail et al.
BLOOD (2013)
Specific gene delivery to liver sinusoidal and artery endothelial cells
Tobias Abel et al.
BLOOD (2013)
Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy
Virginia Hernandez-Gea et al.
JOURNAL OF HEPATOLOGY (2013)
Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
Alexander Wehr et al.
JOURNAL OF IMMUNOLOGY (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
Guanhua Xie et al.
GASTROENTEROLOGY (2012)
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Juliane S. Troeger et al.
GASTROENTEROLOGY (2012)
Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats
Feng Li et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Retinoic acids and hepatic stellate cells in liver disease
Young-Sun Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
Andreas Glaessner et al.
LABORATORY INVESTIGATION (2012)
Suppression of Innate Immunity (Natural Killer Cell/Interferon-γ) in the Advanced Stages of Liver Fibrosis in Mice
Won-Il Jeong et al.
HEPATOLOGY (2011)
Evaluation of polyanion-coated biodegradable polymeric micelles as drug delivery vehicles
Yuichi Ohya et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Hedgehog signaling in the liver
Alessia Omenetti et al.
JOURNAL OF HEPATOLOGY (2011)
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells
Erica Novo et al.
JOURNAL OF HEPATOLOGY (2011)
IL-13 Induces Connective Tissue Growth Factor in Rat Hepatic Stellate Cells via TGF-β-Independent Smad Signaling
Yan Liu et al.
JOURNAL OF IMMUNOLOGY (2011)
Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer
George M. Philips et al.
PLOS ONE (2011)
Anti-PDGF-B monoclonal antibody reduces liver fibrosis development
Shinji Ogawa et al.
HEPATOLOGY RESEARCH (2010)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Diverse Roles of Invariant Natural Killer T Cells in Liver Injury and Fibrosis Induced by Carbon Tetrachloride
Ogyi Park et al.
HEPATOLOGY (2009)
Hepatic Recruitment of the Inflammatory Gr1+ Monocyte Subset Upon Liver Injury Promotes Hepatic Fibrosis
Karlin Raja Karlmark et al.
HEPATOLOGY (2009)
Liver biopsy: The best, not the gold standard
Pierre Bedossa et al.
JOURNAL OF HEPATOLOGY (2009)
Senescence of activated stellate cells limits liver fibrosis
Valery Krizhanovsky et al.
CELL (2008)
Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence
Laurie D. DeLeve et al.
HEPATOLOGY (2008)
Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis
Claudia Pinto Marques Souza de Oliveira et al.
HEPATOLOGY RESEARCH (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis
AC de Gouville et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Fibrotic disease and the TH1/TH2 paradigm
TA Wynn
NATURE REVIEWS IMMUNOLOGY (2004)
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats
CJ Parsons et al.
HEPATOLOGY (2004)
Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis
P Taimr et al.
HEPATOLOGY (2003)
Endothelial cell-mediated uptake of a hepatitis B virus: A new concept of liver targeting of hepatotropic microorganisms
KM Breiner et al.
HEPATOLOGY (2001)
CD44 binds a chondroitin sulfate proteoglycan, aggrecan
T Fujimoto et al.
INTERNATIONAL IMMUNOLOGY (2001)
Share Paper
